際際滷shows by User: timopler / http://www.slideshare.net/images/logo.gif 際際滷shows by User: timopler / Tue, 21 Apr 2020 20:02:16 GMT 際際滷Share feed for 際際滷shows by User: timopler COVID-19 and its Impact on the Biopharma Financing and Deal Environment /slideshow/covid19-and-its-impact-on-the-biopharma-financing-and-deal-environment/232382554 covid-19-torreya-report-april2020-200421200216
COVID-19 and its Impact on the Biopharma Financing and Deal Environment]]>
COVID-19 and its Impact on the Biopharma Financing and Deal Environment]]> Tue, 21 Apr 2020 20:02:16 GMT /slideshow/covid19-and-its-impact-on-the-biopharma-financing-and-deal-environment/232382554 timopler@slideshare.net(timopler) COVID-19 and its Impact on the Biopharma Financing and Deal Environment timopler COVID-19 and its Impact on the Biopharma Financing and Deal Environment <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/covid-19-torreya-report-april2020-200421200216-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> COVID-19 and its Impact on the Biopharma Financing and Deal Environment
COVID-19 and its Impact on the Biopharma Financing and Deal Environment from Tim Opler
]]> 339 0 https://cdn.slidesharecdn.com/ss_thumbnails/covid-19-torreya-report-april2020-200421200216-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Trends in Oncology Pharmaceuticals Business Development /slideshow/trends-in-oncology-pharmaceuticals-business-development/176318353 sachs-oncology-bd-trends-torreya-sep26-2019-190926114651
This presentation provides an overview of the evolving marketplace for oncology transactions and is a summary of discussion materials shared by Torreya at the Sachs Conference on September 26, 2019 in Basel, Switzerland.]]>
This presentation provides an overview of the evolving marketplace for oncology transactions and is a summary of discussion materials shared by Torreya at the Sachs Conference on September 26, 2019 in Basel, Switzerland.]]> Thu, 26 Sep 2019 11:46:51 GMT /slideshow/trends-in-oncology-pharmaceuticals-business-development/176318353 timopler@slideshare.net(timopler) Trends in Oncology Pharmaceuticals Business Development timopler This presentation provides an overview of the evolving marketplace for oncology transactions and is a summary of discussion materials shared by Torreya at the Sachs Conference on September 26, 2019 in Basel, Switzerland. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/sachs-oncology-bd-trends-torreya-sep26-2019-190926114651-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> This presentation provides an overview of the evolving marketplace for oncology transactions and is a summary of discussion materials shared by Torreya at the Sachs Conference on September 26, 2019 in Basel, Switzerland.
Trends in Oncology Pharmaceuticals Business Development from Tim Opler
]]> 811 2 https://cdn.slidesharecdn.com/ss_thumbnails/sachs-oncology-bd-trends-torreya-sep26-2019-190926114651-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Future of the Global Pharmaceutical Industry /slideshow/future-of-the-global-pharmaceutical-industry/79332941 pharmafuture-torreyatalk-sep2017-170831190914
Key points in presentation from Torreya Partners. Despite concerns regarding research productivity and pricing pressure, Torreya is optimistic about the pharma sector. There is huge growth ahead driven by expanding global wealth. The global pharma sector is going to at least triple in scale between now and 2060. The pharmaceutical sector is 30% larger than shown by prior data. New technologies in manufacture, biologics, nucleic acids and implantables will dramatically alter the pharma sector. ]]>
Key points in presentation from Torreya Partners. Despite concerns regarding research productivity and pricing pressure, Torreya is optimistic about the pharma sector. There is huge growth ahead driven by expanding global wealth. The global pharma sector is going to at least triple in scale between now and 2060. The pharmaceutical sector is 30% larger than shown by prior data. New technologies in manufacture, biologics, nucleic acids and implantables will dramatically alter the pharma sector. ]]> Thu, 31 Aug 2017 19:09:14 GMT /slideshow/future-of-the-global-pharmaceutical-industry/79332941 timopler@slideshare.net(timopler) Future of the Global Pharmaceutical Industry timopler Key points in presentation from Torreya Partners. Despite concerns regarding research productivity and pricing pressure, Torreya is optimistic about the pharma sector. There is huge growth ahead driven by expanding global wealth. The global pharma sector is going to at least triple in scale between now and 2060. The pharmaceutical sector is 30% larger than shown by prior data. New technologies in manufacture, biologics, nucleic acids and implantables will dramatically alter the pharma sector. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/pharmafuture-torreyatalk-sep2017-170831190914-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Key points in presentation from Torreya Partners. Despite concerns regarding research productivity and pricing pressure, Torreya is optimistic about the pharma sector. There is huge growth ahead driven by expanding global wealth. The global pharma sector is going to at least triple in scale between now and 2060. The pharmaceutical sector is 30% larger than shown by prior data. New technologies in manufacture, biologics, nucleic acids and implantables will dramatically alter the pharma sector.
Future of the Global Pharmaceutical Industry from Tim Opler
]]> 5585 11 https://cdn.slidesharecdn.com/ss_thumbnails/pharmafuture-torreyatalk-sep2017-170831190914-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-timopler-48x48.jpg?cb=1721756348 Tim Opler is a Partner at Torreya Partners where he provides advisory services to life sciences companies. Torreya Partners is a Leading Life Sciences M&A Boutique. His current clients include a wide variety of biotechnology companies, specialty pharmaceutical companies, medical device companies and diagnostics companies. He has advised on more than 100 transactions at Torreya including partnership deals, M&A transactions and financings. He has strong interest in the areas of allergy, fibrosis and nephrology. Most recently he was Vice-President, Strategy at FibroGen. At FibroGen, Tim was involved in a number of strategic, financial and operational matters. Previously, Tim was a Managing D... http://www.torreyapartners.com https://cdn.slidesharecdn.com/ss_thumbnails/covid-19-torreya-report-april2020-200421200216-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/covid19-and-its-impact-on-the-biopharma-financing-and-deal-environment/232382554 COVID-19 and its Impac... https://cdn.slidesharecdn.com/ss_thumbnails/sachs-oncology-bd-trends-torreya-sep26-2019-190926114651-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/trends-in-oncology-pharmaceuticals-business-development/176318353 Trends in Oncology Pha... https://cdn.slidesharecdn.com/ss_thumbnails/pharmafuture-torreyatalk-sep2017-170831190914-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/future-of-the-global-pharmaceutical-industry/79332941 Future of the Global P...